Wednesday, December 07, 2016 9:34:39 AM
I believe that CTCA www.cancercenter.com/ has taken possession of all the goods and the AVAX patents.
Perhaps CTCA might be interested to go on Nasdaq, using shares of AVAX ...
---------------------------------------------
What do you think about: no progression study of O-vax and restarted study about M-vax?
Estimated Enrollment: 387
Study Start Date: July 2016
Estimated Study Completion Date: January 2021
Estimated Primary Completion Date: January 2019 (Final data collection date for primary outcome measure)
https://clinicaltrials.gov/ct2/show/NCT00477906?term=avax&rank=1
Unfortunately: This study is not yet open for participant recruitment
I sent an email to Dr. Henry but without reply...
CONTACTS:
Contact: Henry E Schea 215 241-9760 ext 1302
henry@avax-tech.com
.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM